Grant: Idea to Innovation
University of Guelph
$61,880.00
Feasibility of transferring high immune response technology to improve the health and food quality of dairy cattle
FY 2010-11
Summary
A novel product was developed and patented by researchers at the University of Guelph to identify animals
with High Immune Response (HIR) capability. The product is a diagnostic service with 4 parts: an
immunization test kit; a laboratory analysis service; a statistical analysis service; and a reporting & consulting
service. HIR has the potential to significantly improve the health and food quality of Canadian dairy cattle
through the reduction of antibiotics and disease treatment costs, and through enhanced resistance to
economically important diseases such as mastitis. Research data indicates that HIR animals are at a lower risk
for developing disease compared to animals that have an average or low immune response. Dairy producers
were approached and asked to give their opinions on the potential value of the HIR Technology. Two market
research focus groups (with 9 & 8 producers, respectively) in two important Ontario dairy regions, were
conducted. Members of the dairy support industry (Veterinarians, Government, Pharmaceutical Companies,
Breeding Companies and Dairy Herd Improvement Companies) were also approached to provide their input on
the technology. Results indicated that there was significant interest (75% of producers) in using HIR to test
calves, sires, or cows for HIR, and that they would use this information for culling decisions, grouping and/or
treating animals with disease. Conclusions drawn from all three focus groups indicate a strong interest in HIR,
but further validation to demonstrate the accuracy and value of HIR technology would be required. To further
investigate the feasibility of transferring HIR to the marketplace, funds are required to: 1) conduct beta-testing
of HIR in cows and heifers from one to two commercial farms to assess the economic benefit of HIR
technology; 2) conduct a field trial for beta-testing HIR technology in a subset of sires to demonstrate that it is
a safe and valuable test; 3) to validate the usefulness of milk whey in lieu of blood as an alternative and
convenient test source for HIR in lactating cattle, 4) concurrently conduct a market assessment of interest in
HIR in approximately 10% (400-450) of Ontario's 4500 dairy farms, & 5) design the HIR business model.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
396297-2010
Name nom
Mallard, Bonnie
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
61880
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5204
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Immunology
Research subject fr
Immunologie
Partie
1
Nb partie
1
Application title
Feasibility of transferring high immune response technology to improve the health and food quality of dairy cattle
Keyword
NSERC
Application summary
A novel product was developed and patented by researchers at the University of Guelph to identify animals
with High Immune Response (HIR) capability. The product is a diagnostic service with 4 parts: an
immunization test kit; a laboratory analysis service; a statistical analysis service; and a reporting & consulting
service. HIR has the potential to significantly improve the health and food quality of Canadian dairy cattle
through the reduction of antibiotics and disease treatment costs, and through enhanced resistance to
economically important diseases such as mastitis. Research data indicates that HIR animals are at a lower risk
for developing disease compared to animals that have an average or low immune response. Dairy producers
were approached and asked to give their opinions on the potential value of the HIR Technology. Two market
research focus groups (with 9 & 8 producers, respectively) in two important Ontario dairy regions, were
conducted. Members of the dairy support industry (Veterinarians, Government, Pharmaceutical Companies,
Breeding Companies and Dairy Herd Improvement Companies) were also approached to provide their input on
the technology. Results indicated that there was significant interest (75% of producers) in using HIR to test
calves, sires, or cows for HIR, and that they would use this information for culling decisions, grouping and/or
treating animals with disease. Conclusions drawn from all three focus groups indicate a strong interest in HIR,
but further validation to demonstrate the accuracy and value of HIR technology would be required. To further
investigate the feasibility of transferring HIR to the marketplace, funds are required to: 1) conduct beta-testing
of HIR in cows and heifers from one to two commercial farms to assess the economic benefit of HIR
technology; 2) conduct a field trial for beta-testing HIR technology in a subset of sires to demonstrate that it is
a safe and valuable test; 3) to validate the usefulness of milk whey in lieu of blood as an alternative and
convenient test source for HIR in lactating cattle, 4) concurrently conduct a market assessment of interest in
HIR in approximately 10% (400-450) of Ontario's 4500 dairy farms, & 5) design the HIR business model.